Media reports had suggested the trip would begin as soon as Sunday and last two days
Roche's Actemra helped the sickest COVID-19 patients in a 303-patient study, the trial's lead investigator said on Thursday, bolstering what has been mixed evidence that the arthritis drug can be repurposed to help in the pandemic.
Actemra, an anti-inflammation drug also called tocilizumab, reached a "key efficacy endpoint" among critically ill patients, compared with patients who did not get immune modulation treatments, according to early REMAP-CAP trial data.
Anthony Gordon, Imperial College London professor of anaesthesia and critical care, said it remained unclear if Actemra kept people alive or shortened how long they needed intensive care support like mechanical ventilation, or both. Those details should be published in a couple of weeks, he said.
Even without specific data, however, Gordon said the study's early signal was robust, with a 99.75% probability that Actemra is better than getting no immune system modulator.
While survival benefit would be ideal, cutting need for intensive care support is also important, since it would reduce the burden on hospitals where occupancy has swelled during the second wave of coronavirus infections.
"We still think that is important," Gordon said on a call with reporters. "But obviously, we hope it improves both, and we're looking for that."
Actemra's trial results against Covid-19 have been mixed.
Roche said in September it helped cut the need for ventilators in hospitalised patients with Covid-19, though the drug failed in a separate study of patients hospitalised with severe COVID-19 related pneumonia.
Other treatments including interferon-beta-1a, interleukin-1 receptor antagonist and Sanofi's arthritis drug Kevzara are also in the REMAP-CAP study, but results are not yet available.
Gordon said the trial's placebo arm - in which patients got no immune modulator - would now be stopped and new patients would get the treatments.
The REMAP-CAP trial separately concluded that AbbVie's AIDS drug cocktail lopinavir/ritonavir didn't help in COVID-19, mirroring results from earlier studies.
Media reports had suggested the trip would begin as soon as Sunday and last two days
Visitors can enjoy movies with family favourites, including ‘The Jungle Book’, ‘Jumanji’ and ‘Zootopia’ to match the wild theme every evening from 8pm
Sheikh Mohamed conveyed his congratulations to all eight honourees, recognising their inspiring efforts and significant contributions in service to society
His father thanked everyone who participated in the search mission despite the challenges posed by flooding in various parts of the emirate
It will be humid by night and Sunday morning with a probability of mist formation over some coastal and internal areas
Nearly 6,000 volunteers linked to a single support group are working tirelessly across the country to help those affected
Real estate developer MAG pledges to cover all the costs of necessary repairs for affected residents
The substantial increase in charges left many residents financially burdened, as they strive to retrieve their stranded vehicles